TELESTA THERAPEUTICS INC T.TST

Groping for answers

[DryBones]

Did our new superstar lead the Dendron marketing team to abject  failure?

Dendron was over $30 bucks when it became apparent that sales of Provenge,  FDA approved immunolgy product would not be able to help the company avoid bankruptcy.  Provenge was the only product of its kind, and proven (whatever proven means) to extend the life of otherwise terminal prostate patients.

Where is dendron now?  It trades at $0.03.  Surely one of the best loved stockes for shorters.

[givmeabrake]

Don't think the saleman is to blame - Analysts expected big things from the Seattle company when Provenge became the first cancer vaccine to win FDA approval. But multiple hurdles--including a hefty $93,000 price tag and stellar launches from new, more convenient rivals Xtandi from Astellas and Medivation, and Zytiga from Johnson & Johnson ($JNJ)--prevented the treatment from living up to

[txbioinv]

drycook aka soft basher, I see your back to your old ways. You should post facts on dendron, not lies. Valeant bought them, they don't even exist or trade anymore. Addtionally, the ex ceo basically sacked the company financially. He was grossly overpaid, borrowed money to fund state of aprt manufacturing plants /sales force INSTEAD of issuing stock to fund. So they couldn't pay the debt

[DryBones]

slander?  you can talk txbionv... I mealy raised a question.